David Georges

Director of Finance/CFO en CELYAD ONCOLOGY SA .

Health Technology

Consumer Services

Perfil

David Georges is currently the Vice President-Finance & Administration at Celyad Oncology SA. Previously, he worked as the Director-Finance & Administration at DIAsource ImmunoAssays SA and as a Financial Manager at Merck KGaA.
Mr. Georges completed his undergraduate degree at Université Catholique de Louvain.

Cargos activos de David Georges

Empresas	Cargo	Inicio
CELYAD ONCOLOGY SA	Director of Finance/CFO	01/01/2019

Todos los cargos activos de David Georges

Antiguos cargos conocidos de David Georges.

Empresas	Cargo	Fin
MERCK KGAA	Corporate Officer/Principal	-
DIAsource ImmunoAssays SA DIAsource ImmunoAssays SA BiotechnologyHealth Technology DIAsource ImmunoAssays SA manufactures and distributes clinical diagnostics products. It develops, manufactures and markets clinical diagnostic products in the field of endocrinology and infectious diseases. The firm offer Elisa reader, washer and shaker, along with open and closed fully automated Elisa platforms helping customers to automate their tests. The company was founded in 1996 and is headquartered in Louvain-la-Neuve, Belgium.	Director of Finance/CFO	-

Ver el detalle de la experiencia de David Georges.

Formación de David Georges.

Université Catholique de Louvain

Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de David Georges.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	2
MERCK KGAA	Health Technology
CELYAD ONCOLOGY SA	Health Technology

Empresas privadas	1
DIAsource ImmunoAssays SA DIAsource ImmunoAssays SA BiotechnologyHealth Technology DIAsource ImmunoAssays SA manufactures and distributes clinical diagnostics products. It develops, manufactures and markets clinical diagnostic products in the field of endocrinology and infectious diseases. The firm offer Elisa reader, washer and shaker, along with open and closed fully automated Elisa platforms helping customers to automate their tests. The company was founded in 1996 and is headquartered in Louvain-la-Neuve, Belgium.	Health Technology